Are Wall Street Analysts Predicting Mettler-Toledo Stock Will Climb or Sink?

Company Overview - Mettler-Toledo International Inc. (MTD) is a manufacturer and supplier of precision instruments and services for laboratory, industrial, and food retailing applications, with a market cap of $28 billion [1] Stock Performance - MTD shares have underperformed the broader market over the past year, gaining 5.7% compared to the S&P 500 Index's nearly 13% increase [2] - In 2026, MTD stock is down 1.2%, while the S&P 500 has seen a marginal rise year-to-date [2] Comparative Analysis - MTD has outperformed the First Trust Indxx Global Medical Devices ETF (MDEV), which has declined about 3% over the past year [3] - MTD's year-to-date dip is less severe than the ETF's 1.4% losses [3] Financial Results - For Q4, MTD reported an adjusted EPS of $13.36, exceeding Wall Street expectations of $12.76, and revenue of $1.13 billion, surpassing forecasts of $1.10 billion [6] - The company anticipates full-year adjusted EPS in the range of $46.05 to $46.70 [6] Earnings Growth and Analyst Ratings - Analysts expect MTD's EPS to grow 8.7% to $46.46 for fiscal 2026 [7] - MTD has consistently beaten consensus estimates in the last four quarters, with a current consensus rating of "Moderate Buy" from 14 analysts [7] - The rating includes six "Strong Buy" and eight "Hold" recommendations [7] Price Targets - Morgan Stanley analyst Kallum Titchmarsh maintains a "Hold" rating with a price target of $1,475, indicating a potential upside of 7.1% [8] - The mean price target is $1,513.69, representing a 9.9% premium to current levels, while the highest price target of $1,700 suggests an upside potential of 23.4% [8]